WO2006095366A1 - Composition édulcorante hypocalorique comprenant de la gomme arabique - Google Patents
Composition édulcorante hypocalorique comprenant de la gomme arabique Download PDFInfo
- Publication number
- WO2006095366A1 WO2006095366A1 PCT/IT2005/000124 IT2005000124W WO2006095366A1 WO 2006095366 A1 WO2006095366 A1 WO 2006095366A1 IT 2005000124 W IT2005000124 W IT 2005000124W WO 2006095366 A1 WO2006095366 A1 WO 2006095366A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- low calorie
- composition
- sweetening
- weight
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 229920000084 Gum arabic Polymers 0.000 title claims abstract description 27
- 239000000205 acacia gum Substances 0.000 title claims abstract description 27
- 235000010489 acacia gum Nutrition 0.000 title claims abstract description 27
- 241000978776 Senegalia senegal Species 0.000 title 1
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 41
- 239000003765 sweetening agent Substances 0.000 claims abstract description 41
- 239000000843 powder Substances 0.000 claims abstract description 27
- 244000215068 Acacia senegal Species 0.000 claims abstract description 26
- 239000004376 Sucralose Substances 0.000 claims abstract description 17
- 235000019408 sucralose Nutrition 0.000 claims abstract description 17
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 17
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims abstract description 16
- 239000000619 acesulfame-K Substances 0.000 claims abstract description 16
- 108010011485 Aspartame Proteins 0.000 claims abstract description 12
- 239000000605 aspartame Substances 0.000 claims abstract description 12
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 12
- 235000010357 aspartame Nutrition 0.000 claims abstract description 12
- 229960003438 aspartame Drugs 0.000 claims abstract description 12
- -1 taumatin Chemical compound 0.000 claims abstract description 6
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims abstract description 5
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims abstract description 3
- 239000004377 Alitame Substances 0.000 claims abstract description 3
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 3
- 235000019409 alitame Nutrition 0.000 claims abstract description 3
- 108010009985 alitame Proteins 0.000 claims abstract description 3
- 229940109275 cyclamate Drugs 0.000 claims abstract description 3
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims abstract description 3
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 claims abstract description 3
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 3
- 150000003839 salts Chemical class 0.000 claims abstract description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 7
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 7
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 4
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 10
- 240000007154 Coffea arabica Species 0.000 description 8
- 235000016213 coffee Nutrition 0.000 description 8
- 235000013353 coffee beverage Nutrition 0.000 description 8
- 238000011835 investigation Methods 0.000 description 8
- 229920005862 polyol Polymers 0.000 description 8
- 150000003077 polyols Chemical class 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 206010016766 flatulence Diseases 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017367 Frequent bowel movements Diseases 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Chemical compound CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000381592 Senegalia polyacantha Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000978782 Vachellia seyal Species 0.000 description 1
- 241001541238 Vachellia tortilis subsp. raddiana Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 229960005168 croscarmellose Drugs 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- This invention relates to a low calorie sweetening composition
- a low calorie sweetening composition comprising one or more intensive sweetening agents and gum arabic.
- a table sweetener in the form of a powder or tablets comprising that composition.
- Sweeteners are generally defined as substances added to food as a replacement for sugar. Among sweeteners so defined "with a low calorie content” there are sweeteners having a mass effect, that is sweeteners which for the same volume as sucrose provide less calories of sweetener substance per gram. Sorbitol, mannitol, isomaltol, maltitol, lactilol and xylitol, generically defined as "polyols or polyalcohols" belong to this class of sweetener.
- Polyalcohols have a common problem as regards their tolerance in the gastrointestinal tract.
- polyalcohols are not digested and absorbed very much in the intestine and this lack of absorption gives rise to consequences which include flatulence, acceleration of intestinal transit time, swelling, increased frequency of defaecation, diarrhoea or constipation.
- These symptoms of gastrointestinal intolerance are in fact typical of osmotically active substances which are not absorbed through an active transport mechanism in the intestine. In the colon these unabsorbed substances feed the bacterial flora, increasing the mass and also forming fermentation products such as short chain fatty acids and gases, for example, hydrogen and methane.
- the laxativity threshold caused by the osmotic loading may vary for different polyols (H. Schiweck, S. C. Ziesenitz "Physiological properties of polyols in comparison with easily metabolisable saccharides, p. 68-69 - Advances in Sweeteners - edited by Grenby - BA&P" ) .
- sweeteners generally known as "intensive sweeteners" which are capable of providing a very low calorific value in association with a strong sweet taste even when added in small quantities is known. Their addition in fact makes it possible to reduce the concentration of polyols in the final sweetener .
- the object of this invention is therefore to provide a low calorie sweetener which has optimum intestinal tolerance which is capable of preventing the adverse collateral effects associated with polyols.
- the invention therefore relates to a low calorie sweetening composition
- a low calorie sweetening composition comprising one or more intensive sweeteners and gum arabic in a percentage by weight within the range 50 to 99%.
- sweetener when used, by this is meant a sweetening composition which can be used in the bulk state for addition in the preparation of sweets, bakery products or drinks, or a table sweetener in the form of powder or tablets for addition to hot or cold drinks, such as for example tea or coffee.
- glycosaccharide a water-soluble polysaccharide which is also known by the names of acacia gum, acacia Senegal or hashab, acacia seyal or talha, gum or acacia polyacantha.
- composition according to the invention contains gum arabic in a percentage by weight with respect to the final composition which lies within the range from 50 to 99%.
- the intensive sweetener is included in the low calorie sweetening composition between 0.1 and 50% by weight with respect to the total weight of the final composition.
- intensive sweeteners may be any sweeteners capable of providing the required degree of sweetness in comparison with sucrose.
- these are one or a mixture of intensive sweeteners selected from the group consisting of sucralose, aspartame, acesulfame K, sodium saccharinate, cyclamate, taumatin, stevia, neohesperidine, alitame and salt of acesulfame K and aspartame.
- the sweetener is one of or a mixture of sucralose and aspartame or sucralose and acesulfame K, even more preferably it is sucralose.
- the low calorie sweetening composition according to the invention may also comprise additives such as fillers, lubricants, fibres, stabilisers, flavourings and/or taste correctors.
- additives such as fillers, lubricants, fibres, stabilisers, flavourings and/or taste correctors.
- fillers microcrystalline cellulose, carboxymethylcellulose or maltodextrin may be cited.
- the fibres inulin fructo-oligosaccharides (FOS) and resistant amides may be cited.
- FOS fructo-oligosaccharides
- resistant amides may be cited.
- the lubricants amino acids preferably leucine, may be cited.
- the invention in another aspect relates to a low calorie table sweetening composition.
- the composition according to the invention may be in the form of a tablet or in the form of powder.
- the intensive sweetener when it is a tablet it will comprise from 20 to 50% of the intensive sweetener by weight with respect to the total weight of the final composition, while when in the form of powder it will comprise from 0.5 to 1.9% of the intensive sweetener by weight with respect to the final composition.
- the composition when it is a tablet it will comprise from 50 to 70% of gum arabic by weight with respect to the total weight of the final composition, while when it is in the form of powder it will comprise an amount of gum arabic higher than 80%, and even more preferably higher than 90%, with respect to the final weight of the composition.
- the low calorie table sweetener according to the invention has proved to be excellently tolerated by the intestine and a good supply of fibre, at the same time ensuring the sweetness required and a low calorie level, as will be shown below. It is also assumed that, thanks to the good probiotic properties of gum arabic, regular ingestion of the low calorie sweetening composition according to the invention may improve digestion, the composition itself acting as a regulator for the intestine.
- Each tablet (50 mg) had the following formulation:
- Example 3 Preparation of low calorie sweetening composition C as tablets.
- Each tablet (53 mg) had the following formulation:
- 1 g of the packed powder had the following formulation: Gum arabic 98.5%
- the sweetening compositions obtained in Examples 1-7 and a 5 gram sample of sucrose as a reference were added to a corresponding number of cups of coffee and the coffees obtained were subjected to the following evaluation.
- Sweetening was judged through tasting the coffee with reference to a scale from 0 to 10, where:
- 0 indicates a very low degree of sweetening, a taste which on tasting was judged to be substantially bitter 5 : ideal value for the normal sweetening of coffee 10: value corresponding to 10 g of sucrose, a taste which on tasting was judged to be excessively sweet.
- Dissolution time was evaluated by dissolving the tablet and powder sweetening compositions in a solution at 65°C, measuring the time necessary for complete disaggregation with slow stirring.
- a panel of 20 healthy adults (10 men and 10 women) was established on the basis of the following criteria:
- the test was divided into two parts corresponding to the tablet and powder compositions.
- the first stage of the investigation was carried out blind.
- the 20 selected individuals drank 5 drinks based on tea and/or coffee each containing 2 grams of a low calorie sweetening composition in powder form having the same percentage ratios indicated for low calorie sweetening composition D in Example 4 over a period of 3 hours.
- powder compositions having ingredients and percentages by weight (out of a total of 2 grams) corresponding to low calorie sweetening compositions E-G were taken following the procedure indicated above and always administering two grams of the composition. At the end of the test the individuals who had experienced one or more of the adverse collateral effects indicated above were counted.
- the above 20 individuals were subjected to the same investigation indicated above for powders, administering the tablets according to the invention. Specifically the 20 individuals drank 5 drinks based on tea and/or coffee, each drink containing 100 mg of a low calorie sweetening composition in tablet form having the same percentage ratios as indicated for sweetening composition A in Example 1 over a period of 3 hours.
- the low calorie sweetening composition according to the invention has proved to provide the same level of sweetening as sucrose and the sweetening composition containing polyols, but in comparison with the latter it was much better tolerated by the intestines.
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Seasonings (AREA)
Abstract
L'invention concerne une composition édulcorante comprenant un ou plusieurs agents édulcorants intenses et de la gomme arabique en pourcentage compris dans l'intervalle allant de 50 à 99 % en poids. De préférence, la composition selon l'invention comprend les agents édulcorants intenses en pourcentage compris dans l'intervalle allant de 0,1 à 50 % en poids par rapport au poids total de la composition. Ces édulcorants intenses peuvent être sélectionnés dans le groupe constitué du sucralose, de l'aspartame, de l'acésulfame K, du saccharinate de sodium, du cyclamate, de la taumatine, du stevia, de la néohespéridine, de l'alitame et du sel d'acésulfame K et d'aspartame. La composition édulcorante est de préférence un édulcorant de table sous forme de poudre ou de comprimés.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2005/000124 WO2006095366A1 (fr) | 2005-03-07 | 2005-03-07 | Composition édulcorante hypocalorique comprenant de la gomme arabique |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2005/000124 WO2006095366A1 (fr) | 2005-03-07 | 2005-03-07 | Composition édulcorante hypocalorique comprenant de la gomme arabique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2006095366A1 true WO2006095366A1 (fr) | 2006-09-14 |
Family
ID=35169333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IT2005/000124 WO2006095366A1 (fr) | 2005-03-07 | 2005-03-07 | Composition édulcorante hypocalorique comprenant de la gomme arabique |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2006095366A1 (fr) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8084073B2 (en) | 2007-03-14 | 2011-12-27 | Concentrate Manufacturing Company Of Ireland | Anisic acid modified steviol glycoside sweetened beverage products |
| WO2012104726A2 (fr) * | 2011-02-01 | 2012-08-09 | E.P.C. (Beijing) Plant Pharmaceutical Technology Co., Ltd | Edulcorant à base de stevia ayant un agent tensioactif |
| CN102940227A (zh) * | 2012-11-30 | 2013-02-27 | 苏州工业园区尚融科技有限公司 | 一种适合在乳饮料中使用的复合甜味剂及其制备方法 |
| US9131718B2 (en) | 2009-06-16 | 2015-09-15 | Epc (Beijing) Natural Products Co., Ltd. | Process for rebaudioside D |
| WO2016038603A1 (fr) * | 2014-09-08 | 2016-03-17 | Maymon Shiri | Composition modifiant l'arôme, ses utilisations et produits en contenant |
| US9314048B2 (en) | 2007-03-14 | 2016-04-19 | The Concentrate Manufacturing Company Of Ireland | Beverage products with non-nutritive sweetener and bitterant |
| US9578895B2 (en) | 2010-08-23 | 2017-02-28 | Epc (Beijing) Natural Products Co., Ltd. | Rebaudioside A and stevioside compositions |
| US9795156B2 (en) | 2011-03-17 | 2017-10-24 | E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd | Rebaudioside B and derivatives |
| US9877500B2 (en) | 2007-03-14 | 2018-01-30 | Concentrate Manufacturing Company Of Ireland | Natural beverage products |
| US10264811B2 (en) | 2014-05-19 | 2019-04-23 | Epc Natural Products Co., Ltd. | Stevia sweetener with improved solubility |
| US10357052B2 (en) | 2014-06-16 | 2019-07-23 | Sweet Green Fields USA LLC | Rebaudioside A and stevioside with improved solubilities |
| US10485256B2 (en) | 2014-06-20 | 2019-11-26 | Sweet Green Fields International Co., Limited | Stevia sweetener with improved solubility with a cyclodextrin |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3294544A (en) * | 1964-11-06 | 1966-12-27 | Richardson Merrell Inc | Artificial sweetener-arabinogalactan composition and edible foodstuff utilizing same |
| JPS5914765A (ja) * | 1982-07-16 | 1984-01-25 | San Ei Chem Ind Ltd | ジペプチド甘味料の耐熱性等付与法 |
| EP0433004A2 (fr) * | 1989-12-14 | 1991-06-19 | Warner-Lambert Company | Tablette de confiserie comprimée de confiserie à libération prolongée de saveur |
| WO1993022939A1 (fr) * | 1992-05-11 | 1993-11-25 | Wm. Wrigley, Jr. Company | Ingredient edulcorant ameliore a forte intensite |
| US5582351A (en) * | 1993-08-09 | 1996-12-10 | Tsau; Josef | Convenient to use aspartame and method of making |
| JP2000175631A (ja) * | 1998-12-11 | 2000-06-27 | Sanei Gen Ffi Inc | 乳化性食品組成物 |
-
2005
- 2005-03-07 WO PCT/IT2005/000124 patent/WO2006095366A1/fr not_active Application Discontinuation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3294544A (en) * | 1964-11-06 | 1966-12-27 | Richardson Merrell Inc | Artificial sweetener-arabinogalactan composition and edible foodstuff utilizing same |
| JPS5914765A (ja) * | 1982-07-16 | 1984-01-25 | San Ei Chem Ind Ltd | ジペプチド甘味料の耐熱性等付与法 |
| EP0433004A2 (fr) * | 1989-12-14 | 1991-06-19 | Warner-Lambert Company | Tablette de confiserie comprimée de confiserie à libération prolongée de saveur |
| WO1993022939A1 (fr) * | 1992-05-11 | 1993-11-25 | Wm. Wrigley, Jr. Company | Ingredient edulcorant ameliore a forte intensite |
| US5582351A (en) * | 1993-08-09 | 1996-12-10 | Tsau; Josef | Convenient to use aspartame and method of making |
| JP2000175631A (ja) * | 1998-12-11 | 2000-06-27 | Sanei Gen Ffi Inc | 乳化性食品組成物 |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE WPI Section Ch Week 198410, 1984 Derwent World Patents Index; Class B05, AN 1984-058387, XP002352549, "stabilisation of dipeptide sweetener - by addn. of gum arabic and opt. thaumatin for synergistic effect" * |
| PATENT ABSTRACTS OF JAPAN vol. 2000, no. 09 13 October 2000 (2000-10-13) * |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9314048B2 (en) | 2007-03-14 | 2016-04-19 | The Concentrate Manufacturing Company Of Ireland | Beverage products with non-nutritive sweetener and bitterant |
| US9877500B2 (en) | 2007-03-14 | 2018-01-30 | Concentrate Manufacturing Company Of Ireland | Natural beverage products |
| US8337928B2 (en) | 2007-03-14 | 2012-12-25 | Concentrate Manufacturing Company Of Ireland | Anisic acid modified steviol glycoside sweetened beverage products |
| US8084073B2 (en) | 2007-03-14 | 2011-12-27 | Concentrate Manufacturing Company Of Ireland | Anisic acid modified steviol glycoside sweetened beverage products |
| US9635878B2 (en) | 2009-06-16 | 2017-05-02 | Epc (Beijing) Natural Products Co., Ltd. | Process for rebaudioside D |
| US9131718B2 (en) | 2009-06-16 | 2015-09-15 | Epc (Beijing) Natural Products Co., Ltd. | Process for rebaudioside D |
| US9578895B2 (en) | 2010-08-23 | 2017-02-28 | Epc (Beijing) Natural Products Co., Ltd. | Rebaudioside A and stevioside compositions |
| US10285425B2 (en) | 2010-08-23 | 2019-05-14 | Epc Natural Products Co. Ltd | Rebaudioside A and stevioside compositions |
| US11202462B2 (en) | 2010-08-23 | 2021-12-21 | Sweet Green Fields International Co., Limited | Rebaudioside A and stevioside compositions |
| WO2012104726A3 (fr) * | 2011-02-01 | 2012-10-04 | E.P.C. (Beijing) Plant Pharmaceutical Technology Co., Ltd | Edulcorant à base de stevia ayant un agent tensioactif |
| WO2012104726A2 (fr) * | 2011-02-01 | 2012-08-09 | E.P.C. (Beijing) Plant Pharmaceutical Technology Co., Ltd | Edulcorant à base de stevia ayant un agent tensioactif |
| US11510428B2 (en) | 2011-03-17 | 2022-11-29 | Sweet Green Fields International Co., Limited | Rebaudioside B and derivatives |
| US9795156B2 (en) | 2011-03-17 | 2017-10-24 | E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd | Rebaudioside B and derivatives |
| CN102940227A (zh) * | 2012-11-30 | 2013-02-27 | 苏州工业园区尚融科技有限公司 | 一种适合在乳饮料中使用的复合甜味剂及其制备方法 |
| US10561165B2 (en) | 2014-05-19 | 2020-02-18 | Sweet Green Fields International Co., Limited | Stevia sweetener with improved solubility |
| US10264811B2 (en) | 2014-05-19 | 2019-04-23 | Epc Natural Products Co., Ltd. | Stevia sweetener with improved solubility |
| US11206857B2 (en) | 2014-05-19 | 2021-12-28 | Sweet Green Fields International Co., Limited | Stevia sweetener with improved solubility |
| US10357052B2 (en) | 2014-06-16 | 2019-07-23 | Sweet Green Fields USA LLC | Rebaudioside A and stevioside with improved solubilities |
| US10568351B2 (en) | 2014-06-16 | 2020-02-25 | Sweet Green Fields USA LLC | Rebaudioside A and stevioside with improved solubilities |
| US11241031B2 (en) | 2014-06-16 | 2022-02-08 | Sweet Green Fields Usa, Llc | Rebaudioside A and stevioside with improved solubilities |
| US10485256B2 (en) | 2014-06-20 | 2019-11-26 | Sweet Green Fields International Co., Limited | Stevia sweetener with improved solubility with a cyclodextrin |
| EA032611B1 (ru) * | 2014-09-08 | 2019-06-28 | Унаву Фуд Текнолоджиз Лтд. | Композиция, которая модифицирует вкусоароматические качества, ее применение и продукты, которые ее содержат |
| US10525136B2 (en) | 2014-09-08 | 2020-01-07 | Unavoo Food Technologies Ltd | Flavor modifying composition, uses thereof and products comprising the same |
| US9884120B2 (en) | 2014-09-08 | 2018-02-06 | Unavoo Food Technologies Ltd | Flavor modifying composition, uses thereof and products comprising the same |
| CN106998770A (zh) * | 2014-09-08 | 2017-08-01 | 尤纳弗食品科技有限公司 | 风味改良组合物、其用途和包含其的产品 |
| US20160295890A1 (en) * | 2014-09-08 | 2016-10-13 | Yuval MAYMON | Flavor modifying composition, uses thereof and products comprising the same |
| WO2016038603A1 (fr) * | 2014-09-08 | 2016-03-17 | Maymon Shiri | Composition modifiant l'arôme, ses utilisations et produits en contenant |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006095366A1 (fr) | Composition édulcorante hypocalorique comprenant de la gomme arabique | |
| ES2811082T3 (es) | Métodos y composiciones para inducir saciedad | |
| JP4793533B2 (ja) | ポリデキストロースでの免疫系の刺激 | |
| ES2230573T3 (es) | Agente anti-obesidad cuyo principio activo es la procianidina. | |
| AU724947B2 (en) | Method of increasing the sweetening power and enhancing the taste of a mixture of high-intensity sweeteners | |
| US20060083795A1 (en) | Meal replacement products having appetite suppressing qualities | |
| JPH07500485A (ja) | 低カロリーチョコレート菓子組成物 | |
| KR20060056274A (ko) | 고감도 감미제 조성물 및 이의 전달 | |
| EP1825857A1 (fr) | Agent visant a ameliorer le temps de transit maximum a travers le tube digestif, agent visant a ameliorer le temps de transit a travers le tube digestif et agent prophylactique pour le cancer du colon | |
| US5651988A (en) | Combination osmotic and bulk forming laxatives | |
| BR112014008692B1 (pt) | Medicamento fluível ou ingerível por colher, alimento, ingrediente alimentício ou suplemento alimentar | |
| BR112016023879B1 (pt) | Composição substituta do açúcar | |
| JP2014532725A (ja) | 下剤および食品サプリメントとしての濃縮プルーンおよびプレバイオティクスの製剤 | |
| WO2016097067A1 (fr) | Composition de remplacement de sucre | |
| JPH1143438A (ja) | カルシウム吸収亢進組成物 | |
| CN114376235A (zh) | 一种有助于控制体内脂肪的减肥益生菌和益生元组合物及其制备方法 | |
| WO2015200842A1 (fr) | Composition comprenant de la metformine et un modulateur du microbiome | |
| US7147883B1 (en) | Compositions containing at least one polyol and inulin characterized by reduced tendencies of the at least one polyol to induce acute diarrhea | |
| CN112741840A (zh) | B族维生素膳食纤维泡腾片及其制备方法 | |
| WO2005006891A1 (fr) | Succedane d'hydrate de carbone | |
| US3684529A (en) | Sweetening compositions | |
| JP5094150B2 (ja) | 血糖値上昇抑制剤 | |
| KR100856678B1 (ko) | 홍삼 음료 조성물 | |
| US20080160086A1 (en) | Delivery Systems For Calcium | |
| EP1618799A1 (fr) | Composition de sucre à faible pouvoir calorifique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 05735065 Country of ref document: EP Kind code of ref document: A1 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 5735065 Country of ref document: EP |